A detailed history of Royal Bank Of Canada transactions in Zomedica Corp. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,750 shares of ZOM stock, worth $357. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,750
Previous 4,091 32.78%
Holding current value
$357
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.12 - $0.16 $160 - $214
-1,341 Reduced 32.78%
2,750 $0
Q2 2024

Aug 14, 2024

BUY
$0.12 - $0.18 $384 - $576
3,200 Added 359.15%
4,091 $0
Q1 2024

Nov 05, 2024

SELL
$0.12 - $0.19 $384 - $608
-3,200 Reduced 78.22%
891 $0
Q1 2024

May 15, 2024

SELL
$0.12 - $0.19 $286 - $453
-2,385 Reduced 72.8%
891 $0
Q4 2023

Feb 14, 2024

BUY
$0.15 - $0.22 $9 - $14
66 Added 2.06%
3,276 $0
Q3 2023

Nov 14, 2023

SELL
$0.16 - $0.23 $24,736 - $35,558
-154,601 Reduced 97.97%
3,210 $0
Q2 2023

Aug 14, 2023

SELL
$0.19 - $0.22 $40 - $46
-213 Reduced 0.13%
157,811 $31,000
Q1 2023

May 15, 2023

BUY
$0.16 - $0.29 $15,008 - $27,203
93,804 Added 146.07%
158,024 $33,000
Q4 2022

Feb 14, 2023

SELL
$0.16 - $0.25 $114 - $178
-713 Reduced 1.1%
64,220 $10,000
Q3 2022

Nov 14, 2022

BUY
$0.2 - $0.38 $5,092 - $9,675
25,462 Added 64.51%
64,933 $14,000
Q2 2022

Aug 15, 2022

BUY
$0.2 - $0.34 $7,345 - $12,486
36,726 Added 1337.92%
39,471 $9,000
Q1 2022

May 16, 2022

SELL
$0.28 - $0.4 $751 - $1,073
-2,684 Reduced 49.44%
2,745 $1,000
Q4 2021

Feb 14, 2022

SELL
$0.31 - $0.58 $1,107 - $2,071
-3,571 Reduced 39.68%
5,429 $2,000
Q3 2021

Nov 15, 2021

SELL
$0.46 - $0.81 $596 - $1,050
-1,297 Reduced 12.6%
9,000 $5,000
Q2 2021

Aug 16, 2021

BUY
$0.72 - $1.46 $7,413 - $15,033
10,297 New
10,297 $9,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.